OSEL, INC.
Biotech · Private
GasK7B, a narrow-spectrum bacteriocin that selectively inhibits Lactobacillus iners to restore chemotherapy and radiation sensitivity in cervical cancer
- Grants
- $3.4M
- 5 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 13
- 2 granted · 11 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201420162018202020222024
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · Delivery of passive immunity against HIV using commensal vaginal Lactobacillus bioengineered to secrete broadly neutralizing domain antibodies | $1,388,546 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of a rapid point of care diagnostic,to monitor MucoCept-CVN, an HIV-targeted biotherapy, | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase II · MucoCept-CVN, a genetically enhanced vaginal Lactobacillus strain for the prevention of HIV acquisition in women: Finalization of formulation for the first-in-human clinical trial | $1,000,000 | |
| Federal grant | Department of Health and Human Services · Phase II · MucoCept-CVN, a genetically enhanced vaginal Lactobacillus strain for the prevention of HIV acquisition in women: Finalization of formulation for the first-in-human clinical trial | $463,683 | |
| Federal grant | Department of Health and Human Services · Phase I · Novel Antimicrobial Approach to Treat Chemoradiation Resistant Cervical Cancer by Selectively Inhibiting Lactobacillus iners | $295,881 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 3152 | ANANEO THERAPEUTICS INC | — | — |
| 3153 | BLOOD CELL TECHNOLOGIES LLC | — | — |
| 3154 | PETAOMICS, INC. | — | — |
| 3155 | OSEL, INC. | — | — |
| 3156 | SERPLUS TECHNOLOGY, LLC | — | — |
| 3157 | ASPIREBIO CORPORATION | — | — |
| 3158 | UNDERDOG PHARMACEUTICALS, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Lactobacillus Crispatus Composition For Use In Pregnant Subjectsapplication
- High Potency Stable Formulations Of Vaginal Lactobacillusgranted
- Bacteriocins To Improve Vaginal Colonization Of Hydrogen Peroxide Producing Lactobacillus For Female Reproductive Healthgranted
- High Potency Stable Formulations Of Vaginal Lactobacillusapplication
- High Potency Stable Formulations Of Vaginal Lactobacillusapplication
- High Potency Stable Formulations Of Vaginal Lactobacillusapplication
- Transiently Buffered Lactobacillus Preparations And Use Thereofapplication
- Applicator For Applying Powder Formulations And Uses Thereofapplication
- Modified Cyanovirin-n Polypeptideapplication
- Surface Expression Of Biologically Active Proteins In Bacteriaapplication
- Lactobacillus Crispatus Composition for Use in Pregnant Subjectsapplication
- Bacteriocins To Improve Vaginal Colonization Of Hydrogen Peroxide Producing Lactobacillus For Female Reproductive Healthapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.